• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科 CLIF-SOFA 评分是预测失代偿性慢性肝病儿童 28 天死亡率的最佳指标。

Pediatric CLIF-SOFA score is the best predictor of 28-day mortality in children with decompensated chronic liver disease.

机构信息

Department of Pediatric Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.

Department of Pediatric Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.

出版信息

J Hepatol. 2018 Mar;68(3):449-455. doi: 10.1016/j.jhep.2017.10.001. Epub 2017 Oct 10.

DOI:10.1016/j.jhep.2017.10.001
PMID:29024698
Abstract

BACKGROUND & AIMS: Early identification of children with decompensated chronic liver disease (DCLD) at risk of short-term mortality helps improve outcome. We aimed to evaluate the predictors of outcome and role of Child-Pugh, pediatric end-stage liver disease (PELD) and pediatric chronic liver failure sequential organ failure assessment (pCLIF-SOFA) score for prognosticating 28-day mortality in children with DCLD.

METHODS

DCLD children were prospectively evaluated with a clinico-laboratory proforma and followed for 28 days to determine outcome. Child-Pugh, PELD and pCLIF-SOFA were calculated at admission. Univariate and multivariate analysis was performed to identify the best predictors of outcome.

RESULTS

A total of 110 children (74 boys, 96 [4-204] months) were enrolled and 37 (33.6%) died at 28 days. Significant risk factors for mortality were a higher international normalized ratio (hazard ratio [HR] 1.17; 95% CI 1.04-1.31; p <0.001) and bilirubin (HR 1.04; 95% CI 1.01-1.08; p <0.001), lower albumin (HR 0.46; 95% CI 0.27-0.77; p = 0.03) and sodium (HR 0.93; 95% CI 0.89-0.98; p = 0.01), absence of treatable etiology (HR 2.00; 95% CI 1.40-2.87; p = 0.001) and presence of organ failure (HR 3.22; 95% CI 1.98-10.58; p <0.001). Organ failure and serum sodium were independent predictors of poor outcome on multivariate analysis. pCLIF-SOFA (16 [9-22] vs. 9 [5-15]), Child-Pugh (11 [9-15] vs. 10 [8-14]) and PELD (22.2 [7.5-45.3] vs. 15.3 [4.5-23.9]) scores were significantly higher in non-survivors. The area under the curve was 0.977 for pCLIF-SOFA, 0.815 for Child-Pugh score, and 0.741 for PELD score. A pCLIF-SOFA score of ≥11 identified 28-day mortality with a sensitivity and specificity of 94.9% and 91.5%, respectively.

CONCLUSION

Thirty-four percent of children with DCLD have a poor short-term outcome. Organ failure and low serum sodium are independent predictors of outcome. pCLIF-SOFA performs better than Child-Pugh and PELD in prognostication of 28-day mortality. Our study supports the use of scores based on organ failure in prognosticating children with DCLD.

LAY SUMMARY

The ability to predict the course of a disease is an important part of the assessment, enabling timely interventions that improve outcomes. We evaluated the outcome (death vs. survival) and compared three different scoring systems for their ability to predict mortality within 28 days in children with decompensated chronic liver disease (DCLD). One-third of children with DCLD died within 28 days and the pediatric chronic liver failure sequential organ failure assessment score, which considers the main organ systems of the body (lungs, liver, brain, kidney, blood and cardiac) fared better for identification of children with a poor outcome than the Child-Pugh and pediatric end-stage liver disease score which comprise of only liver-related parameters. Our study supports the use of scores based on organ failure in prognosticating children with DCLD.

摘要

背景与目的

早期识别有短期死亡风险的失代偿性慢性肝病(DCLD)患儿有助于改善预后。本研究旨在评估预后预测指标,并探讨Child-Pugh、儿童终末期肝病(PELD)和儿童慢性肝衰竭序贯器官衰竭评估(pCLIF-SOFA)评分在预测 DCLD 患儿 28 天死亡率中的作用。

方法

前瞻性评估 DCLD 患儿的临床-实验室记录,并随访 28 天以确定结局。入院时计算 Child-Pugh、PELD 和 pCLIF-SOFA 评分。进行单因素和多因素分析以确定最佳预后预测指标。

结果

共纳入 110 例患儿(男 74 例,96[4-204]月龄),其中 37 例(33.6%)在 28 天内死亡。死亡的显著危险因素包括国际标准化比值较高(危险比[HR] 1.17;95%可信区间 1.04-1.31;p<0.001)和胆红素(HR 1.04;95%可信区间 1.01-1.08;p<0.001)、白蛋白较低(HR 0.46;95%可信区间 0.27-0.77;p=0.03)和钠较低(HR 0.93;95%可信区间 0.89-0.98;p=0.01)、无可治疗病因(HR 2.00;95%可信区间 1.40-2.87;p=0.001)和存在器官衰竭(HR 3.22;95%可信区间 1.98-10.58;p<0.001)。器官衰竭和血清钠是多因素分析中不良结局的独立预测指标。非幸存者的 pCLIF-SOFA(16[9-22]比 9[5-15])、Child-Pugh(11[9-15]比 10[8-14])和 PELD(22.2[7.5-45.3]比 15.3[4.5-23.9])评分显著较高。pCLIF-SOFA 的曲线下面积为 0.977,Child-Pugh 评分为 0.815,PELD 评分为 0.741。pCLIF-SOFA 评分≥11 可识别 28 天死亡率,灵敏度和特异性分别为 94.9%和 91.5%。

结论

34%的 DCLD 患儿短期预后不良。器官衰竭和低血清钠是结局的独立预测指标。pCLIF-SOFA 在预测 28 天死亡率方面优于 Child-Pugh 和 PELD。我们的研究支持使用基于器官衰竭的评分来预测 DCLD 患儿的预后。

相似文献

1
Pediatric CLIF-SOFA score is the best predictor of 28-day mortality in children with decompensated chronic liver disease.儿科 CLIF-SOFA 评分是预测失代偿性慢性肝病儿童 28 天死亡率的最佳指标。
J Hepatol. 2018 Mar;68(3):449-455. doi: 10.1016/j.jhep.2017.10.001. Epub 2017 Oct 10.
2
Quick chronic liver failure-sequential organ failure assessment: an easy-to-use scoring model for predicting mortality risk in critically ill cirrhosis patients.快速慢性肝衰竭-序贯器官衰竭评估:一种用于预测重症肝硬化患者死亡风险的易用评分模型。
Eur J Gastroenterol Hepatol. 2017 Jun;29(6):698-705. doi: 10.1097/MEG.0000000000000856.
3
pCLIF-SOFA is a reliable outcome prognostication score of critically ill children with cirrhosis: an ESPNIC multicentre study.儿童肝硬化危重症的pCLIF-SOFA是一个可靠的预后评分:一项欧洲儿科重症监护学会多中心研究。
Ann Intensive Care. 2020 Oct 14;10(1):137. doi: 10.1186/s13613-020-00753-w.
4
Acute circulatory failure-chronic liver failure-sequential organ failure assessment score: a novel scoring model for mortality risk prediction in critically ill cirrhotic patients with acute circulatory failure.急性循环衰竭-慢性肝衰竭-序贯器官衰竭评估评分:一种用于预测急性循环衰竭的危重症肝硬化患者死亡风险的新型评分模型。
Eur J Gastroenterol Hepatol. 2017 Apr;29(4):464-471. doi: 10.1097/MEG.0000000000000817.
5
Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome.慢性肝衰竭-序贯器官衰竭评估在定义慢加急性肝衰竭和预测预后方面优于亚太肝病研究学会的标准。
World J Gastroenterol. 2014 Oct 28;20(40):14934-41. doi: 10.3748/wjg.v20.i40.14934.
6
Pediatric chronic liver failure-sequential organ failure assessment score and outcome of acute liver failure in children.儿童慢性肝衰竭-序贯器官衰竭评估评分与儿童急性肝衰竭的预后
Clin Exp Hepatol. 2020 Sep;6(3):228-234. doi: 10.5114/ceh.2020.99129. Epub 2020 Sep 18.
7
Prognostication of critically ill patients with acute-on-chronic liver failure using the Chronic Liver Failure-Sequential Organ Failure Assessment: A Canadian retrospective study.使用慢性肝衰竭-序贯器官衰竭评估对急性慢性肝衰竭重症患者进行预后评估:一项加拿大回顾性研究。
J Crit Care. 2016 Dec;36:234-239. doi: 10.1016/j.jcrc.2016.08.003. Epub 2016 Aug 10.
8
Scoring systems for 6-month mortality in critically ill cirrhotic patients: a prospective analysis of chronic liver failure - sequential organ failure assessment score (CLIF-SOFA).用于危重症肝硬化患者 6 个月死亡率的评分系统:慢性肝脏衰竭-序贯器官衰竭评估评分(CLIF-SOFA)的前瞻性分析。
Aliment Pharmacol Ther. 2014 Nov;40(9):1056-65. doi: 10.1111/apt.12953. Epub 2014 Sep 11.
9
How to identify the need for liver transplantation in pediatric acute-on-chronic liver failure?如何在小儿慢加急性肝衰竭中识别肝移植的需求?
Hepatol Int. 2018 Nov;12(6):552-559. doi: 10.1007/s12072-018-9901-y. Epub 2018 Oct 19.
10
CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis.CLIF-SOFA评分系统能准确预测酒精性肝硬化急性失代偿患者的短期死亡率:一项回顾性分析
Liver Int. 2015 Jan;35(1):46-57. doi: 10.1111/liv.12683. Epub 2014 Oct 1.

引用本文的文献

1
Native liver survival with therapeutic plasma exchange in acutely decompensated hepatic Wilson Disease: revisiting the Dhawan index.急性失代偿期肝豆状核变性患者接受治疗性血浆置换后的肝脏存活情况:重新审视达万指数
Hepatol Int. 2025 Aug 12. doi: 10.1007/s12072-025-10891-7.
2
Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia.慢加急性肝衰竭(ACLF):来自亚洲的“京都共识”步骤
Hepatol Int. 2025 Feb;19(1):1-69. doi: 10.1007/s12072-024-10773-4. Epub 2025 Feb 17.
3
Progress on clinical prognosis assessment in liver failure.
肝衰竭临床预后评估的研究进展
Liver Res. 2023 Jun 3;7(2):101-107. doi: 10.1016/j.livres.2023.05.004. eCollection 2023 Jun.
4
Prevalence and Precipitants of Hepatic Encephalopathy in Hospitalized Children With Chronic Liver Disease.慢性肝病住院儿童肝性脑病的患病率及诱发因素
J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101452. doi: 10.1016/j.jceh.2024.101452. Epub 2024 May 31.
5
Hypocoagulability in Children With Decompensated Chronic Liver Disease and Sepsis: Assessment by Thromboelastography.失代偿期慢性肝病合并脓毒症患儿的低凝状态:通过血栓弹力图评估
JPGN Rep. 2023 Jun 9;4(3):e324. doi: 10.1097/PG9.0000000000000324. eCollection 2023 Aug.
6
Poor Access to Liver Transplantation and Survival of Children With Acute Liver Failure, Acute-on-chronic Liver Failure or Chronic Liver Disease.急性肝衰竭、慢加急性肝衰竭或慢性肝病患儿肝移植可及性差与生存率情况
JPGN Rep. 2023 Jun 9;4(3):e318. doi: 10.1097/PG9.0000000000000318. eCollection 2023 Aug.
7
Pediatric acute viral hepatitis with atypical variants: Clinical dilemmas and natural history.具有非典型变异型的小儿急性病毒性肝炎:临床困境与自然病史
World J Hepatol. 2022 May 27;14(5):944-955. doi: 10.4254/wjh.v14.i5.944.
8
Increased INR Values Predict Accelerating Deterioration and High Short-Term Mortality Among Patients Hospitalized With Cirrhosis or Advanced Fibrosis.国际标准化比值(INR)升高预示肝硬化或晚期纤维化住院患者病情加速恶化及短期高死亡率。
Front Med (Lausanne). 2021 Nov 18;8:762291. doi: 10.3389/fmed.2021.762291. eCollection 2021.
9
Evaluation of the Neonatal Sequential Organ Failure Assessment and Mortality Risk in Preterm Infants With Late-Onset Infection.评估早产儿晚发型感染的新生儿序贯器官衰竭评估和死亡风险。
JAMA Netw Open. 2021 Feb 1;4(2):e2036518. doi: 10.1001/jamanetworkopen.2020.36518.
10
Pediatric chronic liver failure-sequential organ failure assessment score and outcome of acute liver failure in children.儿童慢性肝衰竭-序贯器官衰竭评估评分与儿童急性肝衰竭的预后
Clin Exp Hepatol. 2020 Sep;6(3):228-234. doi: 10.5114/ceh.2020.99129. Epub 2020 Sep 18.